TSE:BLU - BELLUS Health Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
C$0.60 0.00 (0.00 %)
(As of 05/24/2018 04:07 AM ET)
Previous CloseC$0.60
Today's RangeC$0.60 - C$0.62
52-Week RangeC$0.31 - C$0.62
Volume113,700 shs
Average Volume203,789 shs
Market CapitalizationC$53.77 million
P/E RatioN/A
Dividend YieldN/A
Beta2.07

About BELLUS Health (TSE:BLU)

BELLUS Health Inc., a biopharmaceutical company, engages in developing novel therapeutics for conditions with high unmet medical need. Its lead drug candidate includes BLU-5937, a small molecule antagonist of the P2X3 receptor for chronic cough. The company also has economic interests in various other partnered clinical-stage drug development programs, including KIACTA, a novel drug candidate for the treatment of patients suffering from active pulmonary sarcoidosis; AMO-01 for Fragile X Syndrome; and ALZ-801 for APOE4 homozygous Alzheimer's disease. BELLUS Health Inc. was founded in 1993 and is based in Laval, Canada.

Receive BLU News and Ratings via Email

Sign-up to receive the latest news and ratings for BLU and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
SymbolTSE:BLU
CUSIPN/A
Phone+1-450-6804500

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-7,295.45%
Return on Equity-36.21%
Return on Assets-32.88%

Miscellaneous

EmployeesN/A
Outstanding Shares119,498,000

BELLUS Health (TSE:BLU) Frequently Asked Questions

What is BELLUS Health's stock symbol?

BELLUS Health trades on the Toronto Stock Exchange (TSX) under the ticker symbol "BLU."

How were BELLUS Health's earnings last quarter?

BELLUS Health Inc. (TSE:BLU) announced its quarterly earnings data on Wednesday, August, 13th. The company reported ($0.02) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.02). The company earned $0.42 million during the quarter, compared to analyst estimates of $1 million. BELLUS Health had a negative net margin of 7,295.45% and a negative return on equity of 36.21%. View BELLUS Health's Earnings History.

When is BELLUS Health's next earnings date?

BELLUS Health is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for BELLUS Health.

Who are some of BELLUS Health's key competitors?

Who are BELLUS Health's key executives?

BELLUS Health's management team includes the folowing people:
  • Mr. Roberto Bellini, Chief Exec. Officer, Pres and Director (Age 38)
  • Mr. François Desjardins CPA, CA, VP of Fin. (Age 55)
  • Dr. Denis Garceau Ph.D., Sr. VP of Drug Devel. (Age 61)
  • Mr. Tony Matzouranis, VP of Bus. Devel. (Age 45)
  • Mr. Sébastien Roy, Corp. Sec. (Age 42)

Has BELLUS Health been receiving favorable news coverage?

News stories about BLU stock have been trending positive on Thursday, according to Accern Sentiment Analysis. The research firm identifies negative and positive media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. BELLUS Health earned a news impact score of 0.33 on Accern's scale. They also gave news articles about the company an impact score of 46.06 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

How do I buy shares of BELLUS Health?

Shares of BLU and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is BELLUS Health's stock price today?

One share of BLU stock can currently be purchased for approximately C$0.60.

How big of a company is BELLUS Health?

BELLUS Health has a market capitalization of C$53.77 million.

How can I contact BELLUS Health?

BELLUS Health's mailing address is 9-275 Armand-Frappier Blvd, LAVAL, QC H7V 4A7, Canada. The company can be reached via phone at +1-450-6804500.


MarketBeat Community Rating for BELLUS Health (BLU)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  53 (Vote Outperform)
Underperform Votes:  51 (Vote Underperform)
Total Votes:  104
MarketBeat's community ratings are surveys of what our community members think about BELLUS Health and other stocks. Vote "Outperform" if you believe BLU will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BLU will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

BELLUS Health (TSE:BLU) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/ABuyBuy
Consensus Rating Score: N/AN/A3.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

BELLUS Health (TSE:BLU) Consensus Price Target History

Price Target History for BELLUS Health (TSE:BLU)

BELLUS Health (TSE:BLU) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
3/1/2017Bloom BurtonReiterated RatingBuyView Rating Details
6/20/2016MackieDowngradeSpeculative Buy ➝ SellView Rating Details
6/20/2016CormarkDowngradeTop Pick ➝ ReduceView Rating Details
(Data available from 5/24/2016 forward)

Earnings

BELLUS Health (TSE:BLU) Earnings History and Estimates Chart

Earnings by Quarter for BELLUS Health (TSE:BLU)

BELLUS Health (TSE BLU) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2018        
2/21/2018Q4 2017C($0.02)C($0.03)C$0.02 millionViewN/AView Earnings Details
11/8/2017Q3 2017C($0.03)C$0.09 millionViewN/AView Earnings Details
5/9/2017Q1 2017C$0.02C$0.01 millionViewN/AView Earnings Details
3/1/2017Q4 2016C($0.02)C($0.01)C$0.36 millionViewN/AView Earnings Details
11/10/2016Q3 2016C($0.01)C($0.01)C$0.45 millionC$0.36 millionViewN/AView Earnings Details
8/9/2016Q2 2016C($0.01)C($0.01)C$0.45 millionC$0.59 millionViewN/AView Earnings Details
5/12/2016Q1 2016C($0.01)C($0.01)C$0.40 millionC$0.59 millionViewN/AView Earnings Details
2/25/2016Q4 2015C($0.01)C$0.02C$0.80 millionC$2.05 millionViewN/AView Earnings Details
8/12/2015Q2 2015C($0.01)C($0.01)C$0.70 millionC$0.59 millionViewN/AView Earnings Details
11/5/2014Q3 2014C($0.02)C($0.01)C$0.50 millionC$0.42 millionViewN/AView Earnings Details
8/13/2014C($0.02)C($0.02)C$1.00 millionC$0.42 millionViewN/AView Earnings Details
5/7/2014Q1 2014C($0.01)C$0.48 millionViewN/AView Earnings Details
2/26/2014Q4 2013C($0.01)C$0.75 millionViewN/AView Earnings Details
11/5/2013Q3 2013C$0.02C$0.53 millionViewN/AView Earnings Details
8/7/2013Q2 2013C($0.02)C$0.38 millionViewN/AView Earnings Details
5/15/2013Q1 2013C($0.01)C$0.60 millionViewN/AView Earnings Details
2/27/2013Q4 2012C($0.01)ViewN/AView Earnings Details
11/8/2012Q3 2012C($0.01)ViewN/AView Earnings Details
8/8/2012Q2 2012C($0.39)ViewN/AView Earnings Details
5/15/2012Q1 2012C($0.30)ViewN/AView Earnings Details
2/22/2012Q4 2011C($0.30)ViewN/AView Earnings Details
11/9/2011Q3 2011C$0.03ViewN/AView Earnings Details
8/10/2011Q2 2011C$0.30ViewN/AView Earnings Details
6/8/2011Q1 2011C$0.30ViewN/AView Earnings Details
2/23/2011Q4 2010C($0.60)ViewN/AView Earnings Details
11/10/2010Q3 2010C($0.90)ViewN/AView Earnings Details
8/9/2010Q2 2010C($0.90)ViewN/AView Earnings Details
5/12/2010Q1 2010C($0.60)ViewN/AView Earnings Details
2/24/2010Q4 2009C($0.93)ViewN/AView Earnings Details
11/10/2009Q3 2009C($1.20)ViewN/AView Earnings Details
8/11/2009Q2 2009C($1.11)ViewN/AView Earnings Details
5/6/2009Q1 2009C($7.06)ViewN/AView Earnings Details
11/10/2008Q3 2008C($6.94)ViewN/AView Earnings Details
5/5/2008Q1 2008C($7.72)ViewN/AView Earnings Details
2/20/2008Q4 2007C($9.70)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

BELLUS Health (TSE:BLU) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

BELLUS Health (TSE BLU) Insider Trading and Institutional Ownership History

Insider Trading History for BELLUS Health (TSE:BLU)

BELLUS Health (TSE BLU) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/2/2017Pierre LarochelleDirectorBuy275,000C$0.36C$99,000.00
7/14/2017Roberto BelliniDirectorBuy225,000C$0.35C$78,750.00
7/20/2015Roberto BelliniDirectorBuy100,000C$1.10C$110,350.00
1/16/2015Francesco BelliniDirectorBuy5,000C$1.03C$5,150.00
(Data available from 1/1/2013 forward)

Headlines

BELLUS Health (TSE BLU) News Headlines

Source:
DateHeadline
BELLUS Health Reports Financial and Operating Results for the First Quarter Ended March 31, 2018BELLUS Health Reports Financial and Operating Results for the First Quarter Ended March 31, 2018
finance.yahoo.com - May 16 at 11:05 AM
BELLUS Health Responds to Recent Share Price Appreciation and Increased Trading ActivityBELLUS Health Responds to Recent Share Price Appreciation and Increased Trading Activity
finance.yahoo.com - April 30 at 3:33 PM
Canadian Exchanges Stock Scanner BELLUS Health, Helius Medical Technologies, Resverlogix and Crescita TherapeuticsCanadian Exchanges Stock Scanner BELLUS Health, Helius Medical Technologies, Resverlogix and Crescita Therapeutics
finance.yahoo.com - April 4 at 12:41 PM
Dairy Alternatives Market Worth $35.06 Billion by 2024 | CAGR: 16.6%: Grand View Research, Inc.Dairy Alternatives Market Worth $35.06 Billion by 2024 | CAGR: 16.6%: Grand View Research, Inc.
www.prnewswire.com - March 15 at 3:41 PM
Healthcare Trust of America, Inc. Announces Appointment of Roberta B. Bowman to the Companys Board of DirectorsHealthcare Trust of America, Inc. Announces Appointment of Roberta B. Bowman to the Company's Board of Directors
www.bizjournals.com - March 15 at 3:41 PM
Anthem Blue Cross Medicare Solutions Center Opens in ChinatownAnthem Blue Cross Medicare Solutions Center Opens in Chinatown
www.bizjournals.com - March 13 at 11:52 AM
Bellus Health: Coughing Its Way To Being Swallowed By Big PharmaBellus Health: Coughing Its Way To Being Swallowed By Big Pharma
seekingalpha.com - March 2 at 3:42 PM
BELLUS Health Reports Financial and Operating Results for the Year Ended December 31, 2017BELLUS Health Reports Financial and Operating Results for the Year Ended December 31, 2017
finance.yahoo.com - February 21 at 11:13 AM
Bill would mandate greater oversight of health plan mergersBill would mandate greater oversight of health plan mergers
www.bizjournals.com - February 8 at 5:13 PM
Canadian Exchanges Stock Scanner, BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita TherapeuticsCanadian Exchanges Stock Scanner, BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita Therapeutics
finance.yahoo.com - January 24 at 8:33 AM
Research Reports on BELLUS Health Helius Medical Technologies, Resverlogix, and Crescita TherapeuticsResearch Reports on BELLUS Health Helius Medical Technologies, Resverlogix, and Crescita Therapeutics
finance.yahoo.com - December 26 at 8:56 AM
BELLUS Health Closes $20M Common Share FinancingBELLUS Health Closes $20M Common Share Financing
finance.yahoo.com - December 12 at 10:01 AM
IIROC Trade Resumption - BELLUS Health Inc.IIROC Trade Resumption - BELLUS Health Inc.
finance.yahoo.com - December 5 at 10:17 AM
IIROC Trade Resumption - BLUIIROC Trade Resumption - BLU
finance.yahoo.com - December 5 at 10:17 AM
BELLUS Health Announces Overnight Marketed Equity OfferingBELLUS Health Announces Overnight Marketed Equity Offering
finance.yahoo.com - December 4 at 5:14 PM
BELLUS Health, Inc. :BLU-CA: Earnings Analysis: Q3, 2017 By the Numbers : November 14, 2017BELLUS Health, Inc. :BLU-CA: Earnings Analysis: Q3, 2017 By the Numbers : November 14, 2017
finance.yahoo.com - November 14 at 5:06 PM
BELLUS Health Reports Financial and Operating Results for the Third Quarter Ended September 30, 2017BELLUS Health Reports Financial and Operating Results for the Third Quarter Ended September 30, 2017
finance.yahoo.com - November 8 at 3:59 PM
Echo Health Ventures Welcomes Nanette DeTurk and Kent Marquardt to the Companys Advisory BoardEcho Health Ventures Welcomes Nanette DeTurk and Kent Marquardt to the Company's Advisory Board
globenewswire.com - October 24 at 11:42 PM
Bham health care real estate firm expandsBham health care real estate firm expands
www.bizjournals.com - October 24 at 11:42 PM
BELLUS Health Inc (BLU) Director Pierre Larochelle Buys 275,000 SharesBELLUS Health Inc (BLU) Director Pierre Larochelle Buys 275,000 Shares
www.americanbankingnews.com - October 3 at 11:16 PM
BELLUS Health Appoints Dr. Clarissa Desjardins to its Board of DirectorsBELLUS Health Appoints Dr. Clarissa Desjardins to its Board of Directors
finance.yahoo.com - October 2 at 12:59 PM
BELLUS Health (BLUSF) Updates On BLU-5937 & Chronic Cough Key Opinion Leader Event - SlideshowBELLUS Health (BLUSF) Updates On BLU-5937 & Chronic Cough Key Opinion Leader Event - Slideshow
seekingalpha.com - September 21 at 4:23 PM
BELLUS Health Chronic Cough Webcast Taking Place TodayBELLUS Health Chronic Cough Webcast Taking Place Today
finance.yahoo.com - September 20 at 5:22 PM
BRIEF-Bellus Healths BLU-5937 reduces cough without taste disturbance in two preclinical modelsBRIEF-Bellus Health's BLU-5937 reduces cough without taste disturbance in two preclinical models
www.reuters.com - September 18 at 4:57 PM
BELLUS Healths Blu-5937 Significantly Reduces Cough Without Taste Disturbance in Two Preclinical ModelsBELLUS Health's Blu-5937 Significantly Reduces Cough Without Taste Disturbance in Two Preclinical Models
finance.yahoo.com - September 18 at 4:57 PM
Report Coverage on Healthcare Stocks, BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita TherapeuticsReport Coverage on Healthcare Stocks, BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita Therapeutics
finance.yahoo.com - September 14 at 5:15 PM
BELLUS Health to host webcast on chronic cough and treatment approach on September 20, 2017BELLUS Health to host webcast on chronic cough and treatment approach on September 20, 2017
finance.yahoo.com - September 6 at 4:38 PM
BELLUS Health, Inc. :BLU-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 15, 2017BELLUS Health, Inc. :BLU-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 15, 2017
finance.yahoo.com - August 15 at 5:27 PM
BELLUS Health Reports Financial and Operating Results for the Second Quarter Ended June 30, 2017BELLUS Health Reports Financial and Operating Results for the Second Quarter Ended June 30, 2017
finance.yahoo.com - August 9 at 4:48 PM
Research Initiated on Healthcare Stocks, BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita TherapeuticsResearch Initiated on Healthcare Stocks, BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita Therapeutics
finance.yahoo.com - August 7 at 5:08 PM
BELLUS Health, Inc. :BLU-CA: Earnings Analysis: Q1, 2017 By the Numbers : August 4, 2017BELLUS Health, Inc. :BLU-CA: Earnings Analysis: Q1, 2017 By the Numbers : August 4, 2017
finance.yahoo.com - August 4 at 9:57 PM
BELLUS Health Inc (BLU) Set to Announce Quarterly Earnings on TuesdayBELLUS Health Inc (BLU) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - August 1 at 7:31 AM
Roberto Bellini Buys 225,000 Shares of BELLUS Health Inc (TSE:BLU) StockRoberto Bellini Buys 225,000 Shares of BELLUS Health Inc (TSE:BLU) Stock
www.americanbankingnews.com - July 18 at 4:18 PM
BELLUS Health Inc. (BLU.TO)BELLUS Health Inc. (BLU.TO)
finance.yahoo.com - July 9 at 4:29 PM
BELLUS Health announces closing of the sale of its equity interest in FB Health for total consideration up to CA$2.5MBELLUS Health announces closing of the sale of its equity interest in FB Health for total consideration up to CA$2.5M
finance.yahoo.com - July 3 at 4:39 PM
Active Wall Street: Research Reports Initiated on Healthcare Stocks BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita TherapeuticsActive Wall Street: Research Reports Initiated on Healthcare Stocks BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita Therapeutics
www.finanznachrichten.de - June 3 at 5:04 AM
Bellus posts 1Q profitBellus posts 1Q profit
marketbeat.com - May 10 at 5:20 AM
IIROC Trading Halt - BLUIIROC Trading Halt - BLU
www.bizjournals.com - March 1 at 8:49 AM
Canadian Stocks Are Rising As Brexit Looks Unlikely -- Canadian CommentaryCanadian Stocks Are Rising As Brexit Looks Unlikely -- Canadian Commentary
www.nasdaq.com - June 22 at 8:38 AM
Savaria, Premium at 52-Week HighsSavaria, Premium at 52-Week Highs
www.baystreet.ca - May 5 at 1:43 PM
Study Reached 120 Qualifying Events, Top-Line Results Expected in Q2 2016Study Reached 120 Qualifying Events, Top-Line Results Expected in Q2 2016
globenewswire.com - January 21 at 10:13 AM

SEC Filings

BELLUS Health (TSE:BLU) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

BELLUS Health (TSE BLU) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.